SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : CEPH -- Ignore unavailable to you. Want to Upgrade?

To: Henry Niman who wrote (852)1/15/1999 5:57:00 PM
From: limit  Respond to of 998
 
Henry,

I saw that also, and CEPH was first company
out of his mouth.

I believe this stock is a really good long term
investment. If Provigal gets some off label
opportunity it could mean $300M in annual revenues.
(my estimate)

Good Luck
limit



To: Henry Niman who wrote (852)1/24/1999 10:08:00 PM
From: LLCF  Read Replies (1) | Respond to of 998
 
And theres this from "Neuroinvestment":

biz.yahoo.com

Wonder whats going on with this stock... how many biotechs do you see with funding guaranteed by their own product?? Isn't this a little rediculous??? He'll they should start buying up the little shits with good science and no coin that fit their profile.

DAK


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News